Kite Pharma Scores $50M For Cancer Immunotherapy

Santa Monica-based Kite Pharma said this morning that it has raised $50M, in a mezzanine, private financing, made up of convertible notes. According to Kite Pharma, the funding came from an un-named syndicate of healthcare-dedicated investors. According to Kite, the new funding will go to advance its programs, which are currently targeting treatments for hematological malignancies and solid tumors. Kite Pharma is led by Dr. Arie Belldegrun. More information »